BioSpace News Archive

Drug Development

Veloxis Pharmaceuticals A/S Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®)

June 30, 2014
·
5 min read
Drug Development

Anavex Life Sciences Corp. Announces Report Expanding Opportunity For Therapeutic Application Of Anavex Compounds

June 30, 2014
·
5 min read
Lone Star Bio

Opexa Therapeutics Joins Russell Microcap Index

June 30, 2014
·
1 min read
Drug Development

Dicerna Pharmaceuticals Release: Researchers Demonstrate Promise Of Dicerna Investigational Therapy In Preclinical Model Of Primary Hyperoxaluria Type 1 (PH1)

June 30, 2014
·
1 min read
Drug Development

Aclaris Therapeutics Announces Positive Results From Phase 2 Clinical Trial Of A-101 For The Removal Of Seborrheic Keratosis, A Common Type Of Skin Tumor

June 30, 2014
·
1 min read
Actavis Confirms Generic Zubsolv® Patent Challenge

June 30, 2014
·
3 min read
FDA

Genzyme Corporation’s Lemtrada Approved In Argentina For Treatment Of Multiple Sclerosis

June 30, 2014
·
1 min read
Genetown

Alnylam Pharmaceuticals Added To Russell 1000 Index As A Member Of The Large-Cap Segment Of The U.S. Equity Universe

June 30, 2014
·
1 min read
Biotech Beach

Senomyx, Inc. Announces Inclusion In The Russell 2000® And Russell 3000® Indexes

June 30, 2014
·
2 min read
Drug Development

Ampio Pharmaceuticals, Inc. Initiates Study of Multiple Injections Of Ampion™ Into The Knees Of Patients With OA Of The Knee To Assess Its Healing And Cartilage Regeneration Effects

June 30, 2014
·
4 min read